Krka Spells Out Chinese Potential With Plans To Double Portfolio In 2022

Slovenian Firm Also Plans To Regroup In West Europe After 11% Sales Tumble

 
• By Dean Rudge
  
China growth
Krka launched pregabalin in China in 2021 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business